Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Spinal Diseases × Melphalan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 144 Lymphoma 72 Lymphoma, Non-Hodgkin 56 Neoplasms, Plasma Cell 49 Leukemia 49 Hodgkin Disease 45 Leukemia, Myeloid, Acute 44 Leukemia, Lymphocytic, Chronic, B-Cell 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Myelodysplastic Syndromes 39 Lymphoma, Large B-Cell, Diffuse 33 Lymphoma, Follicular 33 Lymphoma, Mantle-Cell 32 Lymphoma, Large-Cell, Immunoblastic 25 Burkitt Lymphoma 24 Neuroblastoma 22 Lymphoma, B-Cell, Marginal Zone 21 Recurrence 20 Immunoglobulin Light-chain Amyloidosis 20 Myeloproliferative Disorders 15 Leukemia, Myeloid, Accelerated Phase 15 Hematologic Neoplasms 14 Leukemia, Myelomonocytic, Chronic 13 Leukemia, Myeloid, Chronic-Phase 13 Congenital Abnormalities 13 Melanoma 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Blast Crisis 12 Sarcoma 11 Primary Myelofibrosis 11

Interventions

Melphalan 1 Magnetic Resonance Imaging 1 Infusions, Intra-Arterial 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01637766 2020-08-03

SIAC

Weill Medical College of Cornell University

Phase 1 Completed

Spinal Cord Compression, Spinal Cord Neoplasms, Spinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡